On 2024-02-28, Sensei Biotherapeutics, Inc. (SNSE) announced earnings per share of $-0.30 for the fiscal quarter ending 2023-12-31, beating the average analyst estimate of $-0.32.
The next expected annoucement date for quarterly earnings is 2024-05-14, with an average estimated earnings per share of $-0.29 for the fiscal quarter ending 2024-03-31.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2024-02-28 | 2023-12-31 | $-0.32 | $-0.30 |
| 2023-11-07 | 2023-09-30 | $-0.28 | $-0.28 |
| 2023-08-03 | 2023-06-30 | $-0.32 | $-0.31 |
| 2023-05-09 | 2023-03-31 | $-0.35 | $-0.33 |
| 2023-03-28 | 2022-12-31 | $-0.41 | $-0.40 |
| 2022-11-08 | 2022-09-30 | $-0.37 | $-0.44 |
| 2022-08-09 | 2022-06-30 | $-0.40 | $-0.34 |
| 2022-05-10 | 2022-03-31 | $-0.35 | $-0.40 |
| 2022-03-10 | 2021-12-31 | $-0.34 | $-0.29 |
| 2021-11-09 | 2021-09-30 | $-0.25 | $-0.32 |
| 2021-08-04 | 2021-06-30 | $-0.30 | $-0.32 |
| 2021-05-12 | 2021-03-31 | $-0.33 | $-0.42 |